The clinical implementation of a de-escalation strategy using CYP2C19 genotyping in patients with an acute coronary syndrome: insights from the FORCE-ACS registry

被引：0
|
作者：
Azzahhafi, J. [1 ]
Van den Broek, W. W. A. [1 ]
Yin, D. R. P. P. Chan Pin [1 ]
Ten Berg, J. M. [1 ]
机构：
[1] St Antonius Hosp, Nieuwegein, Netherlands
来源：
EUROPEAN HEART JOURNAL | 2023年 / 44卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页数：1
相关论文
共 50 条
  • [41] The Diagnostic Utility of the Point-of-Care CYP2C19 Genotyping Assay in Patients with Acute Coronary Syndrome Dosing Clopidogrel: Comparison with Platelet Function Test and SNP Genotyping
    Choi, Jae-Lim
    Kim, Bo-Ram
    Woo, Kwang-Sook
    Kim, Kyeong-Hee
    Kim, Jeong-Man
    Kim, Moo-Hyun
    Han, Jin-Yeong
    ANNALS OF CLINICAL AND LABORATORY SCIENCE, 2016, 46 (05): : 489 - 494
  • [42] Smoking and outcomes following guided de-escalation of antiplatelet treatment in acute coronary syndrome patients: a substudy from the randomized TROPICAL-ACS trial
    Orban, Martin
    Trenk, Dietmar
    Geisler, Tobias
    Rieber, Johannes
    Hadamitzky, Martin
    Gross, Lisa
    Orban, Mathias
    Kupka, Danny
    Baylacher, Monika
    Mueller, Susan
    Huber, Kurt
    Koltowski, Lukasz
    Huczek, Zenon
    Heyn, Jens
    Jacobshagen, Claudius
    Aradi, Daniel
    Massberg, Steffen
    Sibbing, Dirk
    Hein, Ralph
    EUROPEAN HEART JOURNAL-CARDIOVASCULAR PHARMACOTHERAPY, 2020, 6 (06) : 372 - 381
  • [43] Prasugrel dose de-escalation in diabetic patients with acute coronary syndrome receiving percutaneous coronary intervention: results from the HOST-REDUCE-POLYTECH-ACS trial
    Lee, Kyu-Sun
    Park, Keun-Ho
    Park, Kyung Woo
    Rha, Seung-Woon
    Hwang, Doyeon
    Kang, Jeehoon
    Han, Jung-Kyu
    Yang, Han-Mo
    Kang, Hyun-Jae
    Koo, Bon-Kwon
    Lee, Nam-ho
    Rhew, Jay Young
    Chun, Kook Jin
    Lim, Young-Hyo
    Bong, Jung Min
    Bae, Jang-Whan
    Lee, Bong Ki
    Kim, Seok-Yeon
    Shin, Won-Yong
    Lim, Hong-Seok
    Park, Kyungil
    Kim, Hyo-Soo
    EUROPEAN HEART JOURNAL-CARDIOVASCULAR PHARMACOTHERAPY, 2023, 9 (03) : 262 - 270
  • [44] IMPACT OF CYP2C19 POLYMORPHISM ON DEVELOPMENT OF ACUTE CORONARY SYNDROME (ACS) IN PATIENTS WITH DECREASED PLASMA LOW-DENSITY LIPOPROTEIN CHOLESTEROL (LDL-C)
    Chitose, Tadasuke
    Hokimoto, Seiji
    Yamamoto, Koichiro
    Ono, Takamichi
    Tsujita, Kenichi
    Kaikita, Koichi
    Sumida, Hitoshi
    Sugiyama, Seigo
    Ogawa, Hisao
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2011, 57 (14) : E935 - E935
  • [45] Is there a benefit for CYP2C19 genotype-guided antiplatelet treatment in elderly acute coronary syndrome patients?
    van den Broek, Wout W. A.
    ten Berg, Jurrien M.
    PHARMACOGENOMICS, 2021, 22 (12) : 727 - 730
  • [46] The Frequency of the Minor Polymorphisms in the CYP2C19, VEGFR-2 Genes, and Clinical Outcomes in Russian and Buryat Patients with Acute Coronary Syndrome
    Zelenskaya, Elena M.
    Lifshits, Galina, I
    Nikolaev, Konstantin Yu
    Donirova, Oyuna S.
    Altayev, Vadim D.
    Apartsin, Konstantin A.
    Voronina, Elena N.
    Protasov, Konstantin, V
    Sychev, Dmitry A.
    GENETIC TESTING AND MOLECULAR BIOMARKERS, 2020, 24 (06) : 338 - 342
  • [47] The impact of CYP2C19 *2 and *3 polymorphism on clopidogrel response following coronary stenting in Saudi patients with acute coronary syndrome
    Khalaf H
    Al Meman A
    Rasool S
    BMC Genomics, 15 (Suppl 2)
  • [48] Genotype-Phenotype Association and Impact on Outcomes following Guided De-Escalation of Anti-Platelet Treatment in Acute Coronary Syndrome Patients: The TROPICAL-ACS Genotyping Substudy
    Gross, Lisa
    Trenk, Dietmar
    Jacobshagen, Claudius
    Krieg, Anne
    Gawaz, Meinrad
    Massberg, Steffen
    Baylacher, Monika
    Aradi, Daniel
    Stimpfle, Fabian
    Hromek, Julia
    Vogelgesang, Anja
    Hadamitzky, Martin
    Sibbing, Dirk
    Geisler, Tobias
    THROMBOSIS AND HAEMOSTASIS, 2018, 118 (09) : 1656 - 1667
  • [49] A BENEFIT-RISK ASSESSMENT OF USING CYP2C19 GENOTYPE INFORMATION TO GUIDE ANTIPLATELET THERAPY IN PATIENTS WITH ACUTE CORONARY SYNDROME
    Guzauskas, G. F.
    Veenstra, D.
    Hughes, D.
    VALUE IN HEALTH, 2010, 13 (03) : A152 - A153
  • [50] Frequency of CYP2C19*2 Allele in Patients with Acute Coronary Syndrome: A Cross-sectional Study from Central Kerala, India
    George, Christina Ann
    Sreedharan, Shibu Thadathil
    Satheesan, Smitha Kalarikkal
    Surendranath, Sindhu Panakkaparambil
    JOURNAL OF CLINICAL AND DIAGNOSTIC RESEARCH, 2021, 15 (10) : BC17 - BC21
12345